SCHEMBL26548722

SCHEMBL26548722

Fc1ccc(-c2ccc3ccc(-c4ccc(-c5cnc6ccccc6c5)nc4)cc3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 4/20 0.48
PDGFRA P16234 4/20 0.48
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47
PIK3CA P42336 5/20 0.47
PIK3CD O00329 4/20 0.47
MTOR P42345 3/20 0.46
CYP2A6 P11509 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
BIRC5 O15392 1/20 0.44
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
TDP2 O95551 1/20 0.41
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548210 0.96 PDGFRB (0.49) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26549233 0.93 PDGFRB (0.50) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26548595 0.90 PDGFRB (0.58) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26548915 0.90 PDGFRB (0.58) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26548688 0.88 CYP1A2 (0.48) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26549189 0.88 PDGFRB (0.47) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26548173 0.87 CYP1A2 (0.50) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26567326 0.86 CYP1A2 (0.49) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26547991 0.85 PDGFRB (0.60) PDGFRBPDGFRANPC1MAPTRAB9A
SCHEMBL26548412 0.85 PDGFRB (0.60) PDGFRBPDGFRANPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 PDGFRB 4867/4885PDGFRA 4853/4885NPC1 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.